Back to Authors

Foltz, Lynda

A5066614305 | I141945490

Mayo Clinic

University of British Columbia

Citations 11

Phase 2 trial of PRM-151, an antifibrotic agent, in patients with myelofibrosis: Stage 1 results.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 7114-7114

10.1200/jco.2014.32.15_suppl.7114